Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-05-18 @ 12:58 PM
Study NCT ID:
NCT00881634
Status:
COMPLETED
Last Update Posted:
2017-03-28
First Post:
2009-04-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
Sponsor:
Sandoz
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2005-984
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Eric Mittleberg, Ph.D, VP of Product Development
Old Organization:
Sandoz Inc.